Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 3318 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Search Again
 Back
 Table of Contents
 
 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Article Access Statistics
 Reader Comments
 Email Alert
 Add to My List
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed417    
    Printed23    
    Emailed0    
    PDF Downloaded55    
    Comments [Add]    

Recommend this journal

 
ARTICLE
Year : 1998  |  Volume : 40  |  Issue : 3  |  Page : 240-246

Treatment of Age-Related Cognitive Decline with a Herbal Formulation : A Double-Blind Study


1 Additional Professor, Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore - 560 029, India
2 Project Assistant, Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore - 560 029, India
3 Additional Professor, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore - 560 029, India

Correspondence Address:
Chittaranjan Andrade
Additional Professor, Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore - 560 029
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 21494479

Rights and PermissionsRights and Permissions

There is little published research in mainstream Indian journals of the clinical psychotropic properties of herbal medicines. The present study therefore evaluated the psychotropic effects of Memorin (from a pharmaceutical house based at Maharashtra), a herbal formulation. Subjects with DSM-IV age-related cognitive decline were randomized to receive Memorin (n=22) or placebo (n=23) for three months. Before and after treatment, all subjects completed a battery of neuropsychological tests that assessed visual and verbal memory, visuospatial skills, and perceptuomotor functioning Subjects and rater were alike blind to treatment group. The results revealed that in the Memorin group, on most tests significant improvement in performances were observed after treatment; improvement in many of the memory tasks was however confined to males; age did not significantly influence the results. In contrast, in placebo-treated subjects there was little therapeutic gain. It is concluded that irrespective of the subject's actual age, Memorin may benefit elderly persons, particularly males, who experience age-related cognitive decline.



[PDF]*

        

Print this article         Email this article